Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate the Efficacy, Safety, and Tolerability of SAGE-324 in Participants With Essential Tremor

ClinicalTrials.gov ID: NCT04305275

Public ClinicalTrials.gov record NCT04305275. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Double-Blind, Placebo-controlled, Randomized Study Evaluating the Efficacy, Safety, and Tolerability of Sage-324 in the Treatment of Individuals With Essential Tremor

Study identification

NCT ID
NCT04305275
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sage Therapeutics
Industry
Enrollment
69 participants

Conditions and interventions

Interventions

  • SAGE-324 Drug
  • SAGE-324 Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 18, 2020
Primary completion
Jan 31, 2021
Completion
Feb 14, 2021
Last update posted
Apr 16, 2024

2020 – 2021

United States locations

U.S. sites
27
U.S. states
17
U.S. cities
26
Facility City State ZIP Site status
Sage Investigational Site Phoenix Arizona 85258
Sage Investigational Site Rogers Arkansas 72758
Sage Investigational Site Fresno California 93710
Sage Investigational Site Long Beach California 90806
Sage Investigational Site Englewood Colorado 80113
Sage Investigational Site Boca Raton Florida 33486
Sage Investigational Site Gainesville Florida 32608
Sage Investigational Site Hollywood Florida 33024
Sage Investigational Site Miami Florida 33136
Sage Investigational Site Miami Florida 33176
Sage Investigational Site Port Charlotte Florida 33980
Sage Investigational Site St. Petersburg Florida 33713
Sage Investigational Site Tampa Florida 33609
Sage Investigational Site Decatur Georgia 30030
Sage Investigational Site Savannah Georgia 31406
Sage Investigational Site Springfield Illinois 62702
Sage Investigational Site Kansas City Kansas 66160
Sage Investigational Site Farmington Hills Michigan 48334
Sage Investigational Site New York New York 10032
Sage Investigational Site Asheville North Carolina 28806
Sage Investigational Site Cincinnati Ohio 45212
Sage Investigational Site Dayton Ohio 45417
Sage Investigational Site Tulsa Oklahoma 74136
Sage Investigational Site Houston Texas 77030
Sage Investigational Site Richmond Virginia 23229
Sage Investigational Site Spokane Washington 99202
Sage Investigational Site Huntington West Virginia 25701

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04305275, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 16, 2024 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04305275 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →